Human monitoring of phthalates and risk assessment

Some phthalates, such as di(2-ethylhexyl) phthalate ( DEHP) and dibutyl phthalate (DBP), and their metabolites are suspected of producing teratogenic and endocrino-disrupting effects. In this study, urinary levels of phthalates ( DEHP, DBP, diethyl phthalate (DEP), butylbenzyl phthalate BBP), and monoethylhexyl phthalate ( MEHP, a major metabolite of DEHP) were measured by high performance liquid chromatography ( HPLC) in human populations ( women [ hospital visitors], n = 150, and children, n = 150). Daily exposure level of DEHP in children was estimated to be 12.4 mu g/kg body weight/d ( male 9.9 mu g/kg body weight/d, female 17.8 mu g/kg body weight/d), but, in women was estimated to be 41.7 mu g/kg body weight/d, which exceeded the tolerable daily intake (TDI, 37 mu g/kg body weight/day) level established by the European Union (EU) Scientific Committee for Toxicity, Ecotoxicity, and the Environment (SCTEE) based on reproductive toxicity. Based on these data, hazard indices (HIs) were calculated to be 1.12 (41.7/37 TDI) for women and 0.33 (12.4/37 TDI) for children, respectively. These data suggest that Koreans ( women and children) were exposed to significant levels of phthalates, which should be reduced to as low a level as technologically feasible to protect Koreans from the exposure to toxic phthalates.